GlobeNewswire 2023-12-07 Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potent...
GlobeNewswire 2023-12-05 IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
GlobeNewswire 2023-11-27 Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Acc...
GlobeNewswire 2023-11-27 Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, ...
GlobeNewswire 2023-11-15 T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to tr...
GlobeNewswire 2023-11-14 MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
GlobeNewswire 2023-11-13 Kymera Therapeutics Announces Publication of Phase 1 Trial Results for KT-474 (SAR444656), a First-i...
GlobeNewswire 2023-11-10 Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial Officer
GlobeNewswire 2023-11-07 Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
TeleTrader 2023-11-07 Sanofi allegedly under inquiry for market manipulation
GlobeNewswire 2023-11-07 PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
GlobeNewswire 2023-11-06 Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-02 The International Myeloma Foundation is Creating an Award-Winning Tool for Nurses to Improve Myeloma...
GlobeNewswire 2023-11-02 Kymera Therapeutics Announces Third Quarter 2023 Financial Results and Provides a Business Update
GlobeNewswire 2023-11-02 Regeneron Reports Third Quarter 2023 Financial and Operating Results
GlobeNewswire 2023-10-30 MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additiona...
TeleTrader 2023-10-27 Europe closes lower after earnings
GlobeNewswire 2023-10-27 Kymera Therapeutics Announces First Patient Dosed in Phase 2 Hidradenitis Suppurativa Clinical Trial...
TeleTrader 2023-10-27 Sanofi shrinks 16% after earnings report
TeleTrader 2023-10-27 Sanofi's Q3 net sales down 4.1% to €11.96B
GlobeNewswire 2023-10-27 Press Release: Specialty Care growth, strong launch uptake of Beyfortus® and ALTUVIIIO® drive solid ...
GlobeNewswire 2023-10-27 Press Release: Sanofi Enters Next Chapter of Play to Win Strategy
GlobeNewswire 2023-10-22 Press Release: Dupixent® (dupilumab) Phase 3 Results show sustained efficacy for up to one year in c...
GlobeNewswire 2023-10-22 Dupixent® (dupilumab) Phase 3 Results Show Sustained Efficacy for Up to One Year in Children 1 to 11...
GlobeNewswire 2023-10-20 Regeneron and Sanofi Provide Update on Dupixent® (dupilumab) sBLA for Chronic Spontaneous Urticaria